Cargando…

203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections

BACKGROUND: Data are conflicting regarding the impact of extended-infusion beta-lactam (EI-BL) therapy on patient outcomes. We investigated the impact of EI-BL therapy on clinical outcomes and subsequent emergence of resistance in adults with Gram-negative bloodstream infections (GN-BSI) admitted to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karaba, Sara M, Hyoung Lee, Jae, Fiawoo, Suiyini, Cosgrove, Sara E, Tamma, Pranita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678729/ http://dx.doi.org/10.1093/ofid/ofad500.276

Ejemplares similares

Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals
por: Ince, Dilek, et al.
Publicado: (2023)

2770. Investigating the Impact of Non-CTX-M Producing ESBL-E Bloodstream Infections on Patient Outcomes
por: Hareza, Dariusz A, et al.
Publicado: (2023)

38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population
por: Karaba, Sara M, et al.
Publicado: (2020)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

Correction to: Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
Publicado: (2023)

An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury
por: Cherian, Jerald P, et al.
Publicado: (2023)

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
por: Thaden, Joshua T., et al.
Publicado: (2022)

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023)

52. Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia
por: Bae, Esther Y, et al.
Publicado: (2020)

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
por: Heil, Emily L, et al.
Publicado: (2021)

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
por: Tamma, Pranita D, et al.
Publicado: (2011)

279. A Decision Tree Using Clinical Characteristics to Predict a Hospitalized Child’s Risk of a Multidrug-Resistant Gram-Negative Bloodstream Infection
por: Sick-Samuels, Anna, et al.
Publicado: (2018)

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse
por: Tamma, Pranita D, et al.
Publicado: (2019)

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives
por: Garcia-Bustos, Víctor, et al.
Publicado: (2022)

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
por: FakhriRavari, Alireza, et al.
Publicado: (2022)

The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal ampC Expression
por: Hareza, Dariusz, et al.
Publicado: (2023)

1881. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Results From a National Antibiotic Stewardship Intervention of 402 United States (US) Hospitals
por: Tamma, Pranita, et al.
Publicado: (2019)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

P1554: SYSTEMATIC REVIEW OF EXTENDED VERSUS BOLUS INFUSION OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS FOR FEBRILE NEUTROPENIA
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

A framework for implementing antibiotic stewardship in ambulatory care: Lessons learned from the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use
por: Keller, Sara C., et al.
Publicado: (2022)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients?
por: Stambaugh, Haley, et al.
Publicado: (2023)

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria
por: Nijssen, Saskia, et al.
Publicado: (2009)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
por: Montiel-Riquelme, Francisco, et al.
Publicado: (2020)

Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections
por: La, Yeon Ju, et al.
Publicado: (2022)

Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?
por: Bassetti, Matteo, et al.
Publicado: (2016)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
por: Maguigan, Kelly L., et al.
Publicado: (2021)

Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review
por: Venuti, Francesco, et al.
Publicado: (2023)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
por: Gatti, Milo, et al.
Publicado: (2021)

Risk factors for colonization with multiple species of extended-spectrum beta-lactamase producing Enterobacterales: a case-case–control study
por: Vock, Isabelle, et al.
Publicado: (2021)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

1827. Comparison of clinical outcomes for glycopeptides and beta-lactams in methicillin-susceptible Staphylococcus aureus bloodstream infections
por: La, Yeon Ju, et al.
Publicado: (2022)

161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic
por: Keller, Sara C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1i91gpc5haqsteu7dgnn5plfp1